期刊文献+

肿瘤患者血清sIL-2R水平变化的临床意义 被引量:1

CLINICAL SIGNIFICANCE OF SERUM sIL-2R LEVEL IN TUMOR PATIENTS
下载PDF
导出
摘要 观察肿瘤患者血清可溶性白细胞介素 2受体 (s IL- 2 R)水平的变化及临床意义。方法 :采用双抗体夹心 EL ISA法对 40例正常人、 30例良性肿瘤及 180例恶性肿瘤患者的血清 s IL- 2 R水平进行测定。结果 :1正常人和良性肿瘤患者血清 s IL-2 R水平较低 ,恶性肿瘤患者明显升高 ,与正常人及良性肿瘤患者比较均有极显著性差异 (P <0 .0 0 1) ;2 s IL- 2 R水平与临床分期及病情严重程度有关 ,处于 、 期的肿瘤患者血清 s IL- 2 R水平显著高于 、 期肿瘤患者 (P <0 .0 1) ;3 6 5例恶性肿瘤患者经手术切除及综合治疗后血清 s IL- 2 R水平较术前明显下降 (P <0 .0 5 )。结论 :恶性肿瘤患者血清 s IL- 2 R水平明显高于正常人及良性肿瘤患者 ,并与病情发展和转归密切相关。 Objective:To observe the changes and clinical significance of the serum sIL 2R level in tumor patients Methods:The level of serum sIL 2R was determined by ELISA method in 40 healthy controls,30 patients with benign tumor and 180 patients with malignant tunor Results:①The level of serum sIL 2R of patients with malignant tumor was significantly higher than that of patients with benign tumor and that of healthy controls (P<0 001);②The serum sIL 2R level correlated with clinical stage and degree of disease,the tumor patients in the stage Ⅲ and Ⅳ had higher sIL 2R level than those who in the stageⅠand Ⅱ;③The level of serum sIL 2R of 65 patients with malignant tumor decreased markedly after treatment with operation,radiotherapy,chemotherapy and biotherapy (P<0 05) Conclusion:The level of serum sIL 2R of patients with malignant tumor was higher than that of healthy controls and that of patients with benign tumor,and correlated with the development of the diseases The level of serum sIL 2R can be used as a useful clinical indicator to diagnose,evaluate the theropeutic effect and assess prognosis
出处 《广西医科大学学报》 CAS 2000年第2期227-228,共2页 Journal of Guangxi Medical University
关键词 血清诊断 SIL-2R 肿瘤 tumor sIL-2R tumor patients
  • 相关文献

参考文献2

二级参考文献1

共引文献19

同被引文献11

  • 1刘艳波,蔡莲莲,王宗敏,赵志光.白细胞介素6在子宫颈癌组织中的表达及其与血管生成的关系[J].中华妇产科杂志,2005,40(3):197-199. 被引量:11
  • 2曾小澜,李新爱,麦羡霞,章碧玉,王鹤皋,程琪辉.恶性肿瘤患者血清sIL-2R的测定及其应用价值的评估[J].中华肿瘤杂志,1996,18(5):358-358. 被引量:8
  • 3Sakata H, Murakami S, Hirayama R, Serum soluble interleukin-2 receptor (IL-2R) and immunohistochemical staining of IL-2R/Tac antigen in colorectal cancer [J]. Int J Clin Oncol, 2002,7(5): 312-317.
  • 4Murakami S, Sakata H, Tsuji Y, et al, Serum soluble interleukin- 2 receptor as a predictor of lymph node metastasis in early gastric cancer [ J ]. Dig Surg, 2002,19 ( 1 ) : 9-13.
  • 5Tartour E, Mosseri V, Jouffroy T, et al. Serum soluble interleukin-2 receptor concentrations as an independent prognostic marker in head and neck cancer [J]. Lancet, 2001,357(9264): 1263 - 1264.
  • 6Grotowski M, Piechot M, Receptors of selected cytokines and angiokine Bfgf in patients with colorectal cancer [J]. Poi Merkuriusz Lek, 2001,11 (65) :398-401,
  • 7Burger R A, Grosen E A, Ioli G R, et al. Spontaneous of release finterleukin-6 by primary cultures of lymphoid and tumor cell populations purified from human overrian carvinoma [J]. J Interferon Cytokine Research, 1995, 15(3):255-260.
  • 8Hussein M Z, A1 Fikky A, Abdel Bar I, et al. Serum IL-6 and IL-12 levels in breast cancer patients [J]. Egypt J Immunol, 2004, 11 (2): 165-170.
  • 9Knupfer H, Preiss R. Significance of interleukin-6 (IL-6) in breast cancer [J]. Breast Cancer Res Treat, 2007,102(2) : 129-135.
  • 10孙玉萍,潘广锦,王薇,汪运山.晚期乳腺癌患者血清白介素6水平的检测[J].肿瘤防治杂志,2000,7(2):219-219. 被引量:7

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部